10.1016/S2213-8587(19)30422-X Summary Keywords GLP-1 receptor agonists, diabetes, coronary artery disease, acute and chronic coronary syndromes, atherosclerosis, coronary microcirculation Citation Pahud de Mortanges A, Sinaci E, Salvador Jr D, Bally L, Muka T, Wilhelm M and Bano A (2022) GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
In rare instances, semaglutide has been linked to more severe conditions such as medullary thyroid carcinoma and gallbladder disease, adding to the need for careful patient monitoring and informed decisions about treatment
As a team that works exclusively with GLP-1 medications like semaglutide (the active ingredient in Ozempic) and tirzepatide, we navigate this world daily
Take charge of your health journey at Sova.Health, where personal care meets results
fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder
This particular peptide combination holds promise for treating leaky gut syndrome
